Bernhard Sperker
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects of Natural Compounds
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacological Effects of Natural Compounds 7
- Pharmacogenetics and Drug Metabolism 5
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Heyo K. KroemerJanne T. BackmanKlaus BossletIngolf CascorbiThomas E. MürdterManfred GerkenPéter FritzWerner Siegmund
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Molecular Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Molecular Microbiology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Bernhard Sperker
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 155
- Oncology 438
- Pediatrics, Perinatology and Child Health 173
- Molecular Biology 551
- Microbiology 48
Countries citing papers authored by Bernhard Sperker
This map shows the geographic impact of Bernhard Sperker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Sperker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Sperker more than expected).
Fields of papers citing papers by Bernhard Sperker
This network shows the impact of papers produced by Bernhard Sperker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Sperker. The network helps show where Bernhard Sperker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernhard Sperker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 5 | |
| 2 | 2004 | 36 | |
| 3 | 2003 | 12 | |
| 4 | 2003 | 41 | |
| 5 | 2003 | 4 | |
| 6 | 2002 | 20 | |
| 7 | 2002 | 7 | |
| 8 | 2002 | 6 | |
| 9 | 2000 | 5 | |
| 10 | 2000 | 72 | |
| 11 | 1999 | 30 | |
| 12 | 1999 | 4 | |
| 13 | 1999 | 20 | |
| 14 | 1999 | 58 | |
| 15 | 1998 | 14 | |
| 16 | 1998 | 1 | |
| 17 | 1997 | 146 | |
| 18 | 1996 | 19 | |
| 19 | 1993 | 17 | |
| 20 | 1991 | 46 |
About Bernhard Sperker
Bernhard Sperker is a scholar working on Pharmacology, Cancer Research, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Pharmacological Effects of Natural Compounds (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Glutathione Transferases and Polymorphisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Pharmacology (155 citations), Oncology (438 citations), Pediatrics, Perinatology and Child Health (173 citations), Molecular Biology (551 citations) and Microbiology (48 citations). Bernhard Sperker has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Heyo K. Kroemer, Janne T. Backman, Klaus Bosslet, Ingolf Cascorbi, Thomas E. Mürdter, Manfred Gerken, Péter Fritz, Werner Siegmund, R Warzok and Peter Dazert. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Molecular Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and Molecular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.